Annual ROE
-19.66%
+0.06%+0.30%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual return on equity is -19.66%, with the most recent change of +0.06% (+0.30%) on December 31, 2023.
- During the last 3 years, XENE annual ROE has risen by +2.24% (+10.23%).
- XENE annual ROE is now -130.02% below its all-time high of 65.50%, reached on December 31, 2013.
Performance
XENE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-24.69%
-0.53%-2.19%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly return on equity is -24.69%, with the most recent change of -0.53% (-2.19%) on September 30, 2024.
- Over the past year, XENE quarterly ROE has dropped by -0.53% (-2.19%).
- XENE quarterly ROE is now -149.58% below its all-time high of 49.80%, reached on September 30, 2014.
Performance
XENE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XENE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.3% | -2.2% |
| 3 y3 years | +10.2% | -5.9% |
| 5 y5 years | +60.3% | -5.9% |
XENE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.1% | -37.9% | +5.9% |
| 5 y | 5-year | at high | +53.9% | -40.8% | +47.2% |
| alltime | all time | -130.0% | +68.0% | -149.6% | +62.3% |
Xenon Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -24.69%(+2.2%) |
| Jun 2024 | - | -24.16%(-0.8%) |
| Mar 2024 | - | -24.35%(-3.3%) |
| Dec 2023 | -19.66%(-0.3%) | -25.18%(-3.2%) |
| Sep 2023 | - | -26.01%(+11.5%) |
| Jun 2023 | - | -23.32%(+16.5%) |
| Mar 2023 | - | -20.01%(+11.8%) |
| Dec 2022 | -19.72%(-9.8%) | -17.90%(-9.2%) |
| Sep 2022 | - | -19.71%(+2.3%) |
| Jun 2022 | - | -19.26%(-12.8%) |
| Mar 2022 | - | -22.09%(-15.8%) |
| Dec 2021 | -21.87%(-0.1%) | -26.23%(-9.2%) |
| Sep 2021 | - | -28.90%(+5.3%) |
| Jun 2021 | - | -27.44%(+48.9%) |
| Mar 2021 | - | -18.43%(+5.1%) |
| Dec 2020 | -21.90%(-48.6%) | -17.53%(-8.7%) |
| Sep 2020 | - | -19.21%(-13.7%) |
| Jun 2020 | - | -22.27%(-37.5%) |
| Mar 2020 | - | -35.63%(-23.8%) |
| Dec 2019 | -42.60% | -46.74%(+11.9%) |
| Sep 2019 | - | -41.78%(-17.0%) |
| Jun 2019 | - | -50.31%(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -54.53%(+4.2%) |
| Dec 2018 | -49.55%(-19.4%) | -52.35%(-17.0%) |
| Sep 2018 | - | -63.08%(-3.7%) |
| Jun 2018 | - | -65.52%(+4.7%) |
| Mar 2018 | - | -62.55%(+2.2%) |
| Dec 2017 | -61.51%(+67.1%) | -61.22%(+21.5%) |
| Sep 2017 | - | -50.40%(+3.4%) |
| Jun 2017 | - | -48.75%(+7.8%) |
| Mar 2017 | - | -45.23%(+20.0%) |
| Dec 2016 | -36.81%(+56.4%) | -37.69%(+10.1%) |
| Sep 2016 | - | -34.24%(+20.8%) |
| Jun 2016 | - | -28.34%(+82.3%) |
| Mar 2016 | - | -15.55%(-34.5%) |
| Dec 2015 | -23.54%(-187.6%) | -23.75%(+37.0%) |
| Sep 2015 | - | -17.33%(-483.4%) |
| Jun 2015 | - | 4.52%(-17.2%) |
| Mar 2015 | - | 5.46%(-83.3%) |
| Dec 2014 | 26.87%(-59.0%) | 32.75%(-34.2%) |
| Sep 2014 | - | 49.80%(+11.0%) |
| Jun 2014 | - | 44.88%(+5.4%) |
| Mar 2014 | - | 42.57%(+15.5%) |
| Dec 2013 | 65.50%(-292.3%) | 36.87% |
| Dec 2012 | -34.07% | - |
FAQ
- What is Xenon Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual ROE year-on-year change?
- What is Xenon Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly ROE year-on-year change?
What is Xenon Pharmaceuticals annual return on equity?
The current annual ROE of XENE is -19.66%
What is the all time high annual ROE for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual return on equity is 65.50%
What is Xenon Pharmaceuticals annual ROE year-on-year change?
Over the past year, XENE annual return on equity has changed by +0.06% (+0.30%)
What is Xenon Pharmaceuticals quarterly return on equity?
The current quarterly ROE of XENE is -24.69%
What is the all time high quarterly ROE for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly return on equity is 49.80%
What is Xenon Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, XENE quarterly return on equity has changed by -0.53% (-2.19%)